Real Event Analysis of the Efficacy and Safety of Polatuzumab Vedotin Combination Regimen in Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaYuanfei Shi, Yi Xu,Jinghan Wang,Xiaolong Zheng,Xueying Li,Jie Jin,Hongyan Tong,Wanzhuo XieBLOOD(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要